A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2004
11/17/2004	CN1546045A Compound medicinal tincture for treating tinea on manus and pedes
11/17/2004	CN1546042A Freeze dried preparation of diammonium glycyrrhizinate and its preparation
11/17/2004	CN1546041A Ursolic acid dripping pills and its preparation process
11/17/2004	CN1546029A Gatifloxacin dispersible tablet and its preparation process
11/17/2004	CN1546023A Sustained release tablet of matrine and its preparing method
11/17/2004	CN1546019A Compound abiduoer preparation with wide spectrum in resisting influenza viral
11/17/2004	CN1546001A Multifunctional skin makeup cream and preparation method thereof
11/17/2004	CN1176210C Novel type coronavirus
11/17/2004	CN1176098C Triplex forming oligonucleotides and their use in anti-HBV
11/17/2004	CN1175891C Ointment painted to nasal cavity for preventing and treating cold and influenza and its preparation
11/17/2004	CN1175889C Hepatopathy treating pills
11/17/2004	CN1175846C Sores and furunculosis treating plaster and preparation thereof
11/17/2004	CN1175845C Chinese traditional medicinal decoction for treating women's genital system diseases
11/17/2004	CN1175841C Antipruritic traditional medicine for treating tinea
11/17/2004	CN1175837C Antiphlogistic honeysuckle flower tablet and its making process
11/17/2004	CN1175825C Medicinal composition for treating common cold
11/17/2004	CN1175815C 1-calcium phosphate-uracil medicine and preparation method
11/17/2004	CN1175809C Use of total bryostatin for preparing medicine for anti SARS coronavirus
11/17/2004	CN1175806C Antibiotic antiinflammation preparation made from extract product of Yunnan loquat as essential component
11/17/2004	CA2470177A1 System and method for controlling user interface properties with data
11/16/2004	US6818761 Comprises heteropolypolysaccharide composed of alternating straight and branched portions consisting of partially acetylated and methylated galacturonic acid residues linked to rhamnose, arabinose and galactose
11/16/2004	US6818750 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation or inflammatory disorders
11/16/2004	US6818653 6,7-Disubstituted -5,8-quinolinedione derivatives as an antifungal agent
11/16/2004	US6818651 Antiinflammatory, antiasthmatic, skin, and autoimmune disorders; crohn*s disease, ulcerative colitis, conjuctivitis, multiple sclerosis, and rheumatoid arthritis; chronic obstructive pulmonary disease
11/16/2004	US6818649 Chromenylmethyl pyrimidinediamines as antibacterial agents
11/16/2004	US6818642 Benzylaminopyrimidines
11/16/2004	US6818638 Melvinolin derivatives
11/16/2004	US6818635 For therapy of bacterial infections and neoplasms,
11/16/2004	US6818634 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds
11/16/2004	US6818633 Antiviral for RNA or DNA viruses such as HIV, HBV or HSV; acyclic pyrimidine nucleoside phosphonate analogues; 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]pyrimidine; ; alkylating the 6-hydroxypyrimidine base with a dialkyl 2-chloroethoxymethylphosphonate
11/16/2004	US6818628 For inducing in a bovine host an immunological response against bovine respiratory syncytial virus or bovine viral diarrhea virus
11/16/2004	US6818615 Antitumor, anticancer agents; synergistic mixture
11/16/2004	US6818611 Stabilized bioactive peptides and methods of identification, synthesis and use
11/16/2004	US6818419 IRAK-4: compositions and methods of use
11/16/2004	US6818224 Using fluid pharmaceutical which allows the controlled release of at least one active substance and which comprises active substance, phospholipid, solvent, fatty acid and can form gel instantaneously for therapy of periodontitis
11/16/2004	US6818222 Particularly from pertussis, cholera and heat labile e. coli
11/16/2004	US6817317 Animal papilla disinfectants and method of improving microbial environment
11/16/2004	CA2525291A1 P. aeruginosa mucoid exopolysaccharide specific binding peptides
11/16/2004	CA2465174A1 Nasal administration of xylitol to a non-human mammal
11/16/2004	CA2145383C O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants
11/16/2004	CA2120342C Epstein-barr virus peptides and antibodies against these peptides
11/14/2004	CA2428703A1 Method for increasing the survival of aquatic and other animals exposed to an aquatic virus, birnavirus or other rna virus and compositions for such methods
11/11/2004	WO2004096823A2 Novel ketolide derivatives
11/11/2004	WO2004096822A2 Pyridyl substituted ketolide antibiotics
11/11/2004	WO2004096818A2 Method and compositions for identifying anti-hiv therapeutic compounds
11/11/2004	WO2004096815A1 Crystals of quinolinecarboxylic acid derivative solvate
11/11/2004	WO2004096813A1 Heterocyclic compounds for use in the treatment of viral infections
11/11/2004	WO2004096807A2 Hiv integrase inhibitors
11/11/2004	WO2004096806A1 Fused imidazole derivative
11/11/2004	WO2004096778A1 Substituted dihydrochinazolines having antiviral properties
11/11/2004	WO2004096774A1 Acyl isoindoline derivatives and acyl isoquinoline derivatives as anti-viral agents
11/11/2004	WO2004096368A1 Treatment of hi-virus infections with oxidised blood proteins
11/11/2004	WO2004096246A1 Antiallergic composition
11/11/2004	WO2004096241A1 Hmpv treatment with ribavirin and anti-hmpv antibody
11/11/2004	WO2004096221A1 Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
11/11/2004	WO2004096210A1 Acylated indoline and tetrahydroquinoline derivatives as hcv inhibitors
11/11/2004	WO2004096197A2 5-aza-7-deazapurine nucleosides for treating flaviviridae
11/11/2004	WO2004096195A2 Use of ppar-gamma agonists as anti-infective agents
11/11/2004	WO2004096194A2 Prevention of hiv-1 infection by inhibition of rho-mediated reorganization and/or content alteration of cell membrane raft domains
11/11/2004	WO2004096187A1 Pharmaceutical composition containing ribavirin as active substance and method of manufacturing thereof
11/11/2004	WO2004073699A8 Pharmaceuticals comprising shikonins as active constituent
11/11/2004	WO2004072052A3 Isoxasole-containing thiourea inhibitors useful for treatment of varicella zoster virus
11/11/2004	WO2004069863A3 Constrained hiv v3 loop peptides as immunogens and receptor antagonists
11/11/2004	WO2004035021A3 Buccal polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
11/11/2004	WO2004010935A3 Methods of treating and preventing rsv, hmpv, and piv using anti-rsv, anti-hmpv, and anti-piv antibodies
11/11/2004	WO2003101394A3 Defensins: use as antiviral agents
11/11/2004	WO2003084988A3 Cd4+ t-lymphocyte-specific hepatitis c virus epitopes
11/11/2004	WO2003077850A3 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors
11/11/2004	WO2003038052A3 Nucleic acid-associated proteins
11/11/2004	WO2003012044A3 Hagfish cathelin-associated antimicrobial peptides and genes
11/11/2004	US20040225123 Substituted phenyl naphthalenes as estrogenic agents
11/11/2004	US20040225118 31 human secreted proteins
11/11/2004	US20040225006 Useful in treatment and prophylaxis of conditions mediated by s-CD23 or tumor necrosis factor; autoimmune disease, inflammation, allergy
11/11/2004	US20040225003 4,6-Dimethyl-3-{[3'-(N,N-dimethylaminomethyl)-4-hydroxy-4'-(3''-methoxyphenyl)-cyclohexylamino]-methyl}-1H-indole 2-carboxylic acid ethyl ester or other derivatives of substituted indoles; for treatment or prevention of neurodegenerative diseases, psychological disorders, AIDS, inflammation or allergies
11/11/2004	US20040224996 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/11/2004	US20040224985 for controlling weight; pyrrolidine or piperidine compounds
11/11/2004	US20040224969 Salts of substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid compounds
11/11/2004	US20040224966 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders
11/11/2004	US20040224960 Pharmaceutical compositions and methods for their use
11/11/2004	US20040224955 Viral polymerase inhibitors
11/11/2004	US20040224941 Carboxylic acid derivatives and drugs containing the same as the active ingredient
11/11/2004	US20040224939 Antibacterial agents
11/11/2004	US20040224929 Novel vitamin D analogs
11/11/2004	US20040224928 For therapy of bacterial infections and neoplasms,
11/11/2004	US20040224926 Inhibitory or blocking agents of molecular generating and/or inducing functions
11/11/2004	US20040224925 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
11/11/2004	US20040224924 Programming a specific course and rate for a parent drug compound's metabolism that leads to an inactive or weakly active and non-toxic metabolite when the parent drug compound is administered, comprising modifying the parent drug compound by forming one or more of a predetermined chemical arrangement
11/11/2004	US20040224923 For therapy of bacterial and/or fungal infections
11/11/2004	US20040224911 Transporters and ion channels
11/11/2004	US20040224908 for treating Gram-positive bacterial infection of skin and soft tissue; remains at therapeutic levels in the bloodstream for 7 days or longer
11/11/2004	US20040224904 Carbohydrate scaffold, carrying two side chains, which form a macrocyclic ring that may be unsaturated and contains ether, amide, ester and/or carbamate groups; for therapy of bacterial, fungal, viral or protozoal infections or tumors
11/11/2004	US20040224883 synergistic administration of a Beta Defensin agent and a beta defensin inducing agent; viricides for chemokine receptor-associated viruses
11/11/2004	US20040224356 Novel human enzymes of the metalloprotease family
11/11/2004	US20040224314 G-protein coupled receptors
11/11/2004	US20040224305 Chimeric human papillomavirus (HPV) L1 molecules and uses therefor
11/11/2004	US20040224023 Compositions and methods for treating or preventing diseases of body passageways
11/11/2004	US20040223997 Antifungal parenteral products
11/11/2004	US20040223982 Neospora vaccine
11/11/2004	US20040223981 administering the live rotavirus immunogenic composition to an infant within seven to ten days of life followed by at least one additional administration of the composition prior to six months of age; does not cause transient low level fever or intussusception,
11/11/2004	US20040223980 Cold-adapted equine influenza viruses

1 ... 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 ... 1798